Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Alzheimer Center Limburg, Maastricht University, Dr. Tanslaan 12, PO Box 616 (DRT 12), 6200 MD, Maastricht, The Netherlands.
Hospital Alvaro Cunqueiro, Department of Psychiatry, Complexo Universitario de Vigo, Vigo, Spain.
Neuropsychol Rev. 2017 Sep;27(3):202-219. doi: 10.1007/s11065-017-9356-2. Epub 2017 Aug 22.
Several brain imaging markers have been studied in the development of post-stroke depression (PSD) and post-stroke apathy (PSA), but inconsistent associations have been reported. This systematic review and meta-analysis aims to provide a comprehensive and up-to-date evaluation of imaging markers associated with PSD and PSA. Databases (Medline, Embase, PsycINFO, CINAHL, and Cochrane Database of Systematic Reviews) were searched from inception to July 21, 2016. Observational studies describing imaging markers of PSD and PSA were included. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to examine the association between PSD or PSA and stroke lesion laterality, type, and location, also stratified by study phase (acute, post-acute, chronic). Other imaging markers were reviewed qualitatively. The search retrieved 4502 studies, of which 149 studies were included in the review and 86 studies in the meta-analyses. PSD in the post-acute stroke phase was significantly associated with frontal (OR 1.72, 95% CI 1.34-2.19) and basal ganglia lesions (OR 2.25, 95% CI 1.33-3.84). Hemorrhagic stroke related to higher odds for PSA in the acute phase (OR 2.58, 95% CI 1.18-5.65), whereas ischemic stroke related to higher odds for PSA in the post-acute phase (OR 0.20, 95% CI 0.06-0.69). Frequency of PSD and PSA is modestly associated with stroke type and location and is dependent on stroke phase. These findings have to be taken into consideration for stroke rehabilitation programs, as this could prevent stroke patients from developing PSD and PSA, resulting in better clinical outcome.
已经有一些脑影像学标志物被研究用于预测卒中后抑郁(PSD)和卒中后淡漠(PSA),但结果并不一致。本系统综述和荟萃分析旨在对与 PSD 和 PSA 相关的影像学标志物进行全面和最新的评估。从建库至 2016 年 7 月 21 日,我们检索了 Medline、Embase、PsycINFO、CINAHL 和 Cochrane 系统评价数据库。纳入描述 PSD 和 PSA 影像学标志物的观察性研究。计算合并优势比(OR)及其 95%置信区间(CI),以评估 PSD 或 PSA 与卒中病灶侧别、类型和部位之间的关系,并根据研究阶段(急性期、亚急性期、慢性期)进行分层。其他影像学标志物进行定性综述。检索得到 4502 篇研究,其中 149 篇研究被纳入综述,86 篇研究被纳入荟萃分析。亚急性期卒中后 PSD 与额叶(OR 1.72,95% CI 1.34-2.19)和基底节病变(OR 2.25,95% CI 1.33-3.84)显著相关。急性期出血性卒中与 PSA 的高风险相关(OR 2.58,95% CI 1.18-5.65),而亚急性期缺血性卒中与 PSA 的高风险相关(OR 0.20,95% CI 0.06-0.69)。PSD 和 PSA 的发生率与卒中类型和部位中度相关,且与卒中阶段相关。在制定卒中康复方案时应考虑这些发现,因为这可能预防卒中患者发展为 PSD 和 PSA,从而获得更好的临床结局。